Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


Articles published in Cutis

Retrieve available abstracts of 17 articles:
HTML format
Text format



Single Articles


    September 2018
  1. KONSTANTINOV NK, Berry TM, Elwood HR, Zlotoff BJ, et al
    Nevus of Ota associated with a primary uveal melanoma and intracranial melanoma metastasis.
    Cutis. 2018;102:E2-E4.
    PubMed     Text format     Abstract available


    June 2018
  2. PEREZ-WILSON J, Arellano J, Castro A
    Polypoid melanoma: an aggressive variant of nodular melanoma.
    Cutis. 2018;101:E6-E7.
    PubMed     Text format    


    May 2018
  3. RAMOT Y, Tetro T, Soteriou L, Doviner V, et al
    Solitary angiokeratoma of the vulva mimicking malignant melanoma.
    Cutis. 2018;101:E6-E7.
    PubMed     Text format    


  4. FARBERG AS, Glazer AM, Winkelmann RR, Tucker N, et al
    Enhanced melanoma diagnosis with multispectral digital skin lesion analysis.
    Cutis. 2018;101:338-340.
    PubMed     Text format     Abstract available


  5. HUSAIN Z, Allawh RM, Hendi A
    Mohs micrographic surgery for digital melanoma and nonmelanoma skin cancers.
    Cutis. 2018;101:346-352.
    PubMed     Text format     Abstract available


    April 2018
  6. HARVEY VM
    Melanoma in US Hispanics: recommended strategies to reduce disparities in outcomes.
    Cutis. 2018;101:243-246.
    PubMed     Text format     Abstract available


    February 2018
  7. SACO M, Zager J, Messina J
    Metastatic melanoma and prostatic adenocarcinoma in the same sentinel lymph node.
    Cutis. 2018;101:E1-E3.
    PubMed     Text format    


    January 2018
  8. NERGARD-MARTIN J, Caldwell C, Barr M, Dellavalle RP, et al
    Perceptions of tanning risk among melanoma patients with a history of indoor tanning.
    Cutis. 2018;101:47.
    PubMed     Text format     Abstract available


  9. SUKHNANDAN F, Kahn MR, Bhattacharjee P
    Nonmalignant cutaneous findings associated with vemurafenib.
    Cutis. 2018;101:E2-E4.
    PubMed     Text format    


    October 2017
  10. KAILAS A, Botwin AL, Pritchett EN, Jackson-Richards D, et al
    Assessing the effectiveness of knowledge-based interventions in increasing skin cancer awareness, knowledge, and protective behaviors in skin of color populations.
    Cutis. 2017;100:235-240.
    PubMed     Text format     Abstract available


    June 2017
  11. CERCI FB, Mesquita LA, Silva de Castro CC
    Segmental vitiligo-like hypopigmentation associated with metastatic melanoma.
    Cutis. 2017;99:E1-E2.
    PubMed     Text format    


    November 2016
  12. GRADY BE, Spencer JM
    Topical imiquimod clears invasive melanoma.
    Cutis. 2016;98:E28-E30.
    PubMed     Text format     Abstract available


    September 2016
  13. GATHINGS RM, Reddy R, Bhatia AC, Brodell RT, et al
    Nevus spilus: is the presence of hair associated with an increased risk for melanoma?
    Cutis. 2016;98:171-174.
    PubMed     Text format     Abstract available


    August 2016
  14. BUSQUETS J, Banala M, Campanelli C, Sahu J, et al
    Subungual onycholemmal cyst of the toenail mimicking subungual melanoma.
    Cutis. 2016;97:107-10.
    PubMed     Text format     Abstract available


  15. KUO KY, Jiang W, Swetter SM
    Enhanced radiation dermatitis associated with concurrent palliative radiation and vemurafenib therapy.
    Cutis. 2016;97:E4-6.
    PubMed     Text format    


  16. USLU U, Hees F, Winnik E, Uter W, et al
    Effectiveness of an employee skin cancer screening program for secondary prevention.
    Cutis. 2016;97:113-9.
    PubMed     Text format     Abstract available


    June 2016
  17. LANOUE J, Chen C, Goldenberg G
    Actinic keratosis as a marker of field cancerization in excision specimens of cutaneous malignancies.
    Cutis. 2016;97:415-20.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: